Viewing Study NCT01801904


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-01-25 @ 3:15 AM
Study NCT ID: NCT01801904
Status: UNKNOWN
Last Update Posted: 2023-03-24
First Post: 2013-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
Sponsor: National Cancer Institute, Naples
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module